Anne-Charlotte Rivière
GoodwinGoodwin houses a broad offering known for its strength in financing mandates, patent infringement actions, and co-development and distribution agreements. Anne-Charlotte Rivière heads the practice, and is recognised for her vast expertise in venture capital, private equity, and M&A work within the life sciences space, particularly in relation to fundraisings. Rivière assists both global and domestic life sciences venture funds. Marie Fillon leads the firm’s IP group, with her primary area of expertise being collaboration, R&D, and manufacturing agreements.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Marie Fillon has an excellent knowledge of the start-up/scale-up environment in France in the healthcare sector.’
‘Very experienced in our sector. Adaptable. Ability to work internationally with US or UK partners. This is important in M&A deals in the healthcare sector. Great brand and great involvement and thoroughness of the teams.’
‘Anne-Charlotte Rivière is experienced in corporate matters in France and internationally for financing operations or complex structured deals.’
‘Anne-Charlotte Rivière: global vision of the issues in the field of life sciences. Marie Fillon: highly valuable business vision.’
Key clients
- Affluent Medical
- AlgoTx
- AQEMIA
- Arkhn
- Biomunex
- Cerba Healthcare
- DNA Script
- DentalMonitoring
- eCential Robotics
- Germitec
- Mablink
- Moon Surgical
- Owkin
- Qynapse
- Robocath
- SurgeCare
- SpineVision
- Stilla Technologies
- Tribun Health
- TRIcares
- UroMems
- Cathay Capital
- Eurazeo
- EW Healthcare Partners
- Go Capital
- Johnson & Johnson Innovation
- Karista
- Kurma Partners
- Lauxera Capital Partners
- Sofinnova Partners
Lawyers
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
The lawyer(s) leading their teams.
Anne-Charlotte Rivière